Coherus Oncology (CHRS) Debt Ratio (2013 - 2026)

Coherus Oncology has disclosed Debt Ratio across 14 years of filings, most recently posting 0.19 for Q2 2026.

• In Q2 2026, Debt Ratio rose 132.23% year-over-year to 0.19; the TTM figure through Jun 2026 stood at 0.19 (up 132.23% YoY), while the FY2025 annual figure was 0.14, up 27.84% from the prior year.
• Debt Ratio came in at 0.19 for Q2 2026 at Coherus Oncology, up from 0.14 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.61 in Q1 2023 to a low of 0.07 in Q2 2024.
• Average Debt Ratio over 5 years is 0.28, with a median of 0.26 recorded in 2024.
• Year-over-year, Debt Ratio surged 359.28% in 2022 and slumped 87.06% in 2024.
• Over 5 years, Debt Ratio stood at 0.51 in 2022, then declined by 22.29% to 0.4 in 2023, then sank by 71.72% to 0.11 in 2024, then increased by 27.84% to 0.14 in 2025, then jumped by 35.84% to 0.19 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.19 in Q2 2026, 0.14 in Q1 2026, and 0.14 in Q4 2025.